Study: RNS60 Drug Stops MS Progression in Mice

Drug will be the subject of a clinical trial in New York.

Study: Ability to Sit & Rise from Floor Is Closely Tied to Mortality Risk

Project examined flexibility and strength in middle-aged adults.


Editor's Note

A Fascinating Debate

Purdue Biochemist Links ALS to Defect in Protein-Transporting Gene

Understanding the role of VAPB could one day lead to treatment and prevention.

Studies: Psoriasis Medication Effective as MS Treatment

New England Journal of Medicine discusses BG-12 findings.

House Passes Pediatric Research Network Bill

Spinal muscular atrophy, Duchenne MD would be among the conditions studied.

Study: Stem Cells in MD Therapy Do Better in Low-Oxygen Environment

Low survival rates may be caused by stem cell "suffocation," researchers say.

University of Pittsburgh to Lead SCI Study

Five-year, multi-site study aims to improve consumers' wheelchair skills.

FDA Approves Lyrica for Neuropathic Pain from SCI

Medication was previously approved for pain from diabetes and fibromyalgia.


SCI Roundup: Ultralights & Propulsion

RESNA’s Position Paper Highlights Ultralight Chair Applications

Report discusses how seat slope, seat-to-back angle, backrest heights and other measurements impact ride.

SCI Roundup: Ultralights & Propulsion

Propulsion Resources

Report: Arthritis Patients Exercise Efforts Often Impeded

Foundation report identifies obstacles and six influential segments that could improve activity levels.

Study: Wheelchair Breakdowns Are Increasing Among Consumers with SCI

Chairs purchased by Medicare and Medicaid experience more breakdowns than those purchased by other payors.

RESNA Launches Position Paper on Ultralight Chairs

Paper describes factors that differentiate ultralight manual chairs from other products.

Consumer News

BraunAbility Infographic: 3.3 Million Wheelchair Users in America

Statistics show the impact of disabilities on daily living.

Kessler Foundation Wins SCI Research Grant

Five-year grant will include study of combination locomotor therapy using dalfampridine.

Report: Power-Assist Market Worth $328 Million by 2017

Study says technology's appeal will rise in next five years.

Kessler Foundation Seeks Employment Experiences from People with Disabilities

Research and advocacy organization celebrates Disability Employment Awareness month.

Online Exclusive!

When Funding Impacts Function

Cushion Customization Project Update

Referrals and Prescriptions podcast